Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Third Rock Ventures IV, L.P. Insider Profile
4 Followers
Third Rock Ventures IV, L.P., Ten Percent Owner at Dianthus Therapeutics, holds 19.20M shares in Tango Therapeutics (Ticker: TNGX), holds 3.06M shares in Dianthus Therapeutics (Ticker: DNTH), holds 1.42M shares in Revolution Medicines (Ticker: RVMD). Most recently, Third Rock Ventures IV, L.P. Sold ― shares of Tango Therapeutics on Feb 21, 2024 for an estimated value of 1.95M.
Third Rock Ventures IV, L.P. Dianthus Therapeutics (DNTH)Ten Percent Owner
Dianthus Therapeutics (DNTH)
Ten Percent Owner
Ranked #66,183 out of 97,372 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-14.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Third Rock Ventures IV, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 22, 2019 - Jul 22, 2020
Return:+39.20%
The most profitable trade made by Third Rock Ventures IV, L.P.
Third Rock Ventures IV, L.P.'s Trading History
Dianthus Therapeutics
Feb 09, 2023
Ten Percent Owner
Informative Sell
3.06M
$78.75M
Fulcrum Therapeutics
Jul 22, 2019
Ten Percent Owner
Informative Buy
1.30M
$25.75M
Revolution Medicines
Feb 18, 2020
Ten Percent Owner
Uninformative Buy
―
$42.31M
Tango Therapeutics
Feb 21, 2024
Ten Percent Owner
Informative Sell
1.95M
$219.66M
List of latest transactions for each holding click on a transaction to see Third Rock Ventures IV, L.P.'s performance on stock
You May Also Like
Third Rock Ventures IV, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Third Rock Ventures IV, L.P.?
The percentage of profitable transactions made by Third Rock Ventures IV, L.P. is 33%.
What is the average return per transaction made by Third Rock Ventures IV, L.P.?
The average return per transaction made by Third Rock Ventures IV, L.P. is -14.60%.
What stocks does Third Rock Ventures IV, L.P. hold?
Third Rock Ventures IV, L.P. holds: DNTH, FULC, RVMD, TNGX stocks.
What was Third Rock Ventures IV, L.P.’s latest transaction?
Third Rock Ventures IV, L.P. latest transaction was an Informative Sell of $1.95M.
What was Third Rock Ventures IV, L.P.'s most profitable transaction?
Third Rock Ventures IV, L.P.’s most profitable transaction was an Informative Buy of FULC stock on July 22, 2019. The return on the trade was 39.20%.
What is Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics?
Third Rock Ventures IV, L.P.'s role in Dianthus Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.